Non-small-cell lung cancers (NSCLCs), the most common lung cancers, are known to have
diverse pathological features. During the past decade, in-depth analyses of lung cancer …

Melatonin is a pleotropic molecule with numerous biological activities. Epidemiological and
experimental studies have documented that melatonin could inhibit different types of cancer …

Abstract Programmed cell death-1 (PD-1)/programmed cell death ligand-1 (PD-L1) blocking
therapy has become a major pillar of cancer immunotherapy. Compared with antibodies …

No predictive biomarkers can robustly identify patients with non–small cell lung cancer
(NSCLC) who will benefit from immune checkpoint inhibitor (ICI) therapies. Here, in a …

Abstract Introduction/Background An individual patient data metaanalysis was performed to
determine clinical outcomes, and to propose a risk stratification system, related to the …

The discovery of chromosomal rearrangements involving the anaplastic lymphoma kinase
(ALK) gene in non‐small cell lung cancer (NSCLC) has stimulated renewed interest in …

RNA methylation is a novel epigenetic modification that can be used to evaluate tumor
prognosis. However, the underlying mechanisms are unclear. This study aimed to …

The National Comprehensive Cancer Network (NCCN) is a not-for-profit alliance of 25 of the
world's leading cancer centers that are devoted to patient care, research, and education …

Progress has been made in the treatment of lung cancer over the past 40 years, albeit at a
modest pace. Cytoxic chemotherapy has improved 5-year survival rates when added to …

lncRNAs can exert many biological effects in several cancer types. MALAT1 is a kind of
lncRNA which is greatly overexpressed in several tumors including non‐small cell lung …